Skip to main content

Table 2 Patient background in substage B1

From: Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification

 

Non-resection

N = 53 (43.1)

Resection

N = 70 (56.9)

P-value

Cohen’s D

Age (years)

70 (51–93)

68 (45–87)

0.121

0.333

Sex

  

0.607

0.165

 Male

43 (81.1)

61 (87.1)

  

 Female

10 (18.9)

9 (12.9)

  

HBV positive

6 (11.3)

10 (14.3)

0.788

0.089

HCV positive

31 (58.5)

50 (71.4)

0.181

0.273

Plt (×104/mm3)

10.5 (3.6–25.5)

12.5 (3.3–189)

0.168

0.214

PT (%)

82 (36–112)

84 (24–112)

0.064

0.312

T-Bil (mg/dL)

0.9 (0.4–2.8)

0.8 (0.3–2.2)

0.013

0.536

AST (IU/L)

42 (17–568)

42 (17–148)

0.513

0.283

ALT (IU/L)

35 (11–834)

39 (11–165)

0.732

0.202

Alb (g/dL)

3.9 (2.8–4.7)

3.9 (2.9–5.2)

0.865

0.102

ICGR15 (%)

23.1 (4.0–66.7)

17.4 (2.6–79.2)

0.008

0.492

AFP (ng/mL)

28.7 (0.5–4172)

14.1 (1.4–8390)

0.211

0.545

DCP (mAU/mL)

74 (10–17,093)

96 (10–32,365)

0.939

0.218

Child-Pugh

43/10 (81.1/18.9)

64/6 (91.4/8.6)

0.106

0.302

 A

43 (81.1)

64 (91.4)

  

 B

10 (18.9)

6 (8.6)

  

Tumor number

2 (2–5)

2 (2–4)

0.116

0.309

Tumor size (mm)

35 (7–46)

36 (10–50)

0.054

0.335

  1. AFP alpha-fetoprotein, Alb albumin, AST asparate aminotransferase, ALT alanine aminotransferase, DCP des-gamma-carboxyprothorombin, HBV hepatitis B virus, HCV hepatitis C virus, ICGR15 indocyanine green retention rate at 15 min, Plt platelet count, PT prothrombin time, T. Bil total bilirubin